Trial Profile
Efficacy and safety of ribavirin+sofosbuvir in patients with hepatitis C virus related cirrhosis: Retrospective study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 22 Dec 2015 New trial record
- 30 Nov 2015 Results published in the Journal of Hepatology